lactic acid has been researched along with enrofloxacin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kyriakis, SC; Sarris, K; Tsiloyiannis, VK; Vlemmas, J | 1 |
| Tsukahara, T; Ushida, K | 1 |
| Fang, S; Hu, K; Jiang, Y; Su, H; Sun, J; Wei, Y; Zheng, R | 1 |
| Astete, CE; Louie, SM; Paudel, S; Peña-Bahamonde, J; Rodrigues, DF; Sabliov, CM; Shakiba, S | 1 |
1 trial(s) available for lactic acid and enrofloxacin
| Article | Year |
|---|---|
The effect of organic acids on the control of post-weaning oedema disease of piglets.
Topics: Animal Feed; Animals; Anti-Infective Agents; Body Weight; Citric Acid; Dietary Supplements; Edema Disease of Swine; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Intestine, Small; Lactic Acid; Male; Quinolones; Swine | 2001 |
3 other study(ies) available for lactic acid and enrofloxacin
| Article | Year |
|---|---|
Organic acid profiles in feces of pigs with pathogenic or non-pathogenic diarrhea.
Topics: Animals; Anti-Infective Agents; Diarrhea; Dyspepsia; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Feces; Female; Fluoroquinolones; Lactic Acid; Male; Quinolones; Succinic Acid; Swine; Swine Diseases | 2001 |
Effects of lactic acid on drug-metabolizing enzymes in Chinese mitten crab (Eriocheir sisnensis) after oral enrofloxacin.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Aquaculture; Aryl Hydrocarbon Hydroxylases; Brachyura; Cytochrome P450 Family 3; Dietary Supplements; Energy Metabolism; Enrofloxacin; Gene Expression Regulation; Hepatopancreas; Inactivation, Metabolic; Lactic Acid; Steroid Hydroxylases | 2019 |
Prevention of infection caused by enteropathogenic E. coli O157:H7 in intestinal cells using enrofloxacin entrapped in polymer based nanocarriers.
Topics: Drug Carriers; Enrofloxacin; Enteropathogenic Escherichia coli; Escherichia coli O157; Lactic Acid; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2021 |